Value Bridge — MAINE MEDICAL CENTER
Current $-86M → Target $-48M (+$37.8M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-85.6M
Current EBITDA
$-47.8M
Target EBITDA
+$37.8M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$8.6M
Payer Mix Optimization
$20.5M
Cost to Collect Reduction
$6.8M
Clean Claim Improvement
$5.1M
Volume & Rate Growth
$34.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-86M to $-48M. The highest-impact lever is Volume & Rate Growth at $13.7M probability-weighted.
IC talking point: "We see $38M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $416M in equity value creation."